Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.622 USD | +3.05% | +15.38% | +19.23% |
05-09 | Earnings Flash (ATRA) ATARA BIOTHERAPEUTICS Reports Q1 Revenue $27.4M | MT |
04-01 | Stifel Adjusts Atara Biotherapeutics Price Target to $2.30 From $4.80, Maintains Hold Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.23% | 72.68M | |
+8.77% | 114B | |
+10.85% | 104B | |
-12.88% | 22.41B | |
-1.14% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-5.09% | 17.89B | |
+7.78% | 14.28B | |
+36.45% | 12.55B |
- Stock Market
- Equities
- ATRA Stock
- News Atara Biotherapeutics, Inc.
- Citigroup Downgrades Atara Biotherapeutics to Neutral From Buy, Sets $8 Price Target